121 related articles for article (PubMed ID: 12713881)
1. Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation.
Zuckerman E
J Hepatol; 2003 May; 38(5):674-6. PubMed ID: 12713881
[No Abstract] [Full Text] [Related]
2. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
Zuckerman E; Slobodin G; Kessel A; Sabo E; Yeshurun D; Halas K; Toubi E
Clin Exp Immunol; 2002 May; 128(2):353-8. PubMed ID: 11985527
[TBL] [Abstract][Full Text] [Related]
3. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.
Curry MP; Golden-Mason L; Doherty DG; Deignan T; Norris S; Duffy M; Nolan N; Hall W; Hegarty JE; O'Farrelly C
J Hepatol; 2003 May; 38(5):642-50. PubMed ID: 12713876
[TBL] [Abstract][Full Text] [Related]
4. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
[TBL] [Abstract][Full Text] [Related]
5. Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.
Zuckerman E; Kessel A; Slobodin G; Sabo E; Yeshurun D; Toubi E
J Virol; 2003 Oct; 77(19):10432-6. PubMed ID: 12970428
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.
Ni J; Hembrador E; Di Bisceglie AM; Jacobson IM; Talal AH; Butera D; Rice CM; Chambers TJ; Dustin LB
J Immunol; 2003 Mar; 170(6):3429-39. PubMed ID: 12626604
[TBL] [Abstract][Full Text] [Related]
7. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection.
Curry MP; Golden-Mason L; Nolan N; Parfrey NA; Hegarty JE; O'Farrelly C
J Hepatol; 2000 Jan; 32(1):121-5. PubMed ID: 10673076
[TBL] [Abstract][Full Text] [Related]
8. CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia.
Russi S; Vincenti A; Vinella A; Mariggiò MA; Pavone F; Dammacco F; Lauletta G
Eur J Intern Med; 2019 Aug; 66():48-56. PubMed ID: 31126779
[TBL] [Abstract][Full Text] [Related]
9. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.
Rosa D; Saletti G; De Gregorio E; Zorat F; Comar C; D'Oro U; Nuti S; Houghton M; Barnaba V; Pozzato G; Abrignani S
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18544-9. PubMed ID: 16339892
[TBL] [Abstract][Full Text] [Related]
10. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
[TBL] [Abstract][Full Text] [Related]
11. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
[TBL] [Abstract][Full Text] [Related]
12. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
[TBL] [Abstract][Full Text] [Related]
13. A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes.
Zhang H; Gregorio JD; Iwahori T; Zhang X; Choi O; Tolentino LL; Prestwood T; Carmi Y; Engleman EG
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1988-1993. PubMed ID: 28167780
[TBL] [Abstract][Full Text] [Related]
14. CD5 expression in human B-cell populations.
Youinou P; Jamin C; Lydyard PM
Immunol Today; 1999 Jul; 20(7):312-6. PubMed ID: 10379049
[TBL] [Abstract][Full Text] [Related]
15. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81.
Miyazaki T; Müller U; Campbell KS
EMBO J; 1997 Jul; 16(14):4217-25. PubMed ID: 9250665
[TBL] [Abstract][Full Text] [Related]
16. Binding of hepatitis C virus to CD81.
Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
[TBL] [Abstract][Full Text] [Related]
17. The identification and characterization of a ligand for bovine CD5.
Haas KM; Estes DM
J Immunol; 2001 Mar; 166(5):3158-66. PubMed ID: 11207268
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients.
Mizuochi T; Ito M; Takai K; Yamaguchi K
Biochem Biophys Res Commun; 2009 Nov; 389(3):512-5. PubMed ID: 19737536
[TBL] [Abstract][Full Text] [Related]
19. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
20. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
